Met Life Investment Management, LLC Dyne Therapeutics, Inc. Transaction History
Met Life Investment Management, LLC
- $18 Billion
- Q4 2024
A detailed history of Met Life Investment Management, LLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 49,467 shares of DYN stock, worth $673,245. This represents 0.01% of its overall portfolio holdings.
Number of Shares
49,467
Previous 46,719
5.88%
Holding current value
$673,245
Previous $1.68 Million
30.57%
% of portfolio
0.01%
Previous 0.01%
Shares
21 transactions
Others Institutions Holding DYN
# of Institutions
213Shares Held
103MCall Options Held
135KPut Options Held
435K-
Atlas Venture Life Science Advisors, LLC8.02MShares$109 Million31.16% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$101 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.38MShares$100 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.7MShares$91.2 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.38MShares$86.8 Million2.43% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $705M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...